Jinyu Bio Technology Co Stock Shares Owned By Institutions

600201 Stock   6.94  0.24  3.58%   
Jinyu Bio Technology Co fundamentals help investors to digest information that contributes to Jinyu Bio's financial success or failures. It also enables traders to predict the movement of Jinyu Stock. The fundamental analysis module provides a way to measure Jinyu Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jinyu Bio stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Jinyu Bio Technology Co Company Shares Owned By Institutions Analysis

Jinyu Bio's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

More About Shares Owned By Institutions | All Equity Analysis

Current Jinyu Bio Shares Owned By Institutions

    
  11.95 %  
Most of Jinyu Bio's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jinyu Bio Technology Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Competition

Based on the latest financial disclosure, 11.95% of Jinyu Bio Technology Co are shares owned by institutions. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The shares owned by institutions for all China stocks is notably lower than that of the firm.

Jinyu Shares Owned By Institutions Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jinyu Bio's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jinyu Bio could also be used in its relative valuation, which is a method of valuing Jinyu Bio by comparing valuation metrics of similar companies.
Jinyu Bio is currently under evaluation in shares owned by institutions category among its peers.

Jinyu Fundamentals

About Jinyu Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Jinyu Bio Technology Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jinyu Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jinyu Bio Technology Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Jinyu Stock

Jinyu Bio financial ratios help investors to determine whether Jinyu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jinyu with respect to the benefits of owning Jinyu Bio security.